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Models of vocal communication 
generally involve interactions between 
the perception and production 
systems that allow the tuning of motor 
commands to achieve sound targets 
[3]. Our results shed further light on 
these models by indicating that the 
auditory pathways necessary for vocal 
performance are, to some degree at 
least, distinct from those necessary 
for conscious perception. The fact 
that tone-deaf individuals show no 
clear impairment in perceiving and 
producing speech provides further 
support for this conclusion. The 
distinction between auditory streams 
for production and perception 
demonstrated here may be analogous 
to separate visual streams for action 
and perception [9]. Further studies 
may aim to identify the precise neural 
correlates of this perception–action 
mismatch, and relate behavioral 
manifestations of tone- deafness to 
observed neurobiological anomalies in 
this unique population [10]. 
Supplemental data
Supplemental data are available at http://
www.current-biology.com/cgi/content/
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Figure 2. Variable pitch production by 
tone-deaf individuals.
(A) Mean fundamental frequencies of the two 
produced tones in tone-deaf listeners. The 
first tone had a target frequency at a constant 
500 Hz, whereas the second tone ranged 
from 450-550 Hz. (B) Same as A in normal 
controls. While both groups show a signifi-
cant positive correlation between target and 
produced fundamental frequency, the correla-
tion is significantly lower in the tone-deaf group 
(t(1,10) = 2.3, p = 0.046) and variability in pitch 
production is higher for the tone-deaf group, 
as indicated by a t-test comparing standard 
error across different subjects producing the 
same pitch: t(1,20) = 3.6, p = 0.0015. Error bars 
indicate between-subject standard error.FGF induces 
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Many biological processes, such 
as circadian rhythms and somite 
segmentation [1], are regulated 
by molecular clocks. During 
somitogenesis, mRNAs for Notch 
signaling molecules, such as the Notch 
effector Hes1, oscillate periodically [1]. 
Here, we show that FGF stimulation 
induces the oscillatory expression of 
Hes1 in an ERK-dependent manner 
and also induces oscillatory activation 
of Ras and ERK activities. Our analysis 
demonstrates that oscillations in Ras/
ERK activity require negative-feedback 
phosphorylation of Sos by ERK, 
suggesting that Ras/ERK oscillations 
could act as a novel molecular clock.
The oscillatory expression of Hes1 
is triggered by serum stimulation in 
several cultured cell lines [2]. As FGF 
has been implicated in the regulation 
of somite segmentation [3], we 
examined whether FGF stimulation 
induces oscillation of Hes1 expression. 
Treatment of C3H 10T1/2 cells with 
bFGF induced the oscillation of hes1 
mRNA and Hes1 protein with a 2 hour 
cycle (Figure 1A and Figure S1 in 
Supplemental Data, published with this 
article online). To examine the potential 
involvement of the MEK–ERK pathway 
in triggering the oscillatory expression 
of Hes1, we examined the effects 
of U0126, a specific MEK inhibitor. 
Pretreatment with U0126 almost 
completely inhibited bFGF- induced 
oscillatory expression of Hes1 
(Figure 1A). Moreover, pretreatment  
with another MEK inhibitor  
(PD98059) or expression of the  
MAPK phosphatase CL100/MKP1  
suppressed the ERK activation and 
Hes1 oscillation (data not shown). 
DAPT, an inhibitor of γ-secretase, which 
cleaves Notch, did not prevent the Hes1 
oscillation (data not shown). When 
U0126 was added to cells  
110 min after FGF stimulation, the later 
rise in hes1 expression was suppressed 
(Figure 1C). Unexpectedly, we then 
found that ERK phosphorylation, and 
therefore activity, oscillated in response 
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Figure 1. FGF-induced oscillations of Hes1 expression and ERK activation. 
(A) hes1 mRNA levels were determined every 20 min after bFGF (25 ng/ml) treatment of C3H 10T1/2 cells. Cells were pretreated 30 min before 
bFGF stimulation with DMSO (pink line) or with 20 µM U0126 (black line). (B) Cell extracts were subjected to immunoblotting analysis with anti-
bodies against ERK and phosphorylated ERK (P-ERK). Three independent experiments gave similar results. (C) The effects of addition of U0126 
(black line, final 20 µM) to C3H 10T1/2 cells at 110 min after bFGF treatment (arrow). (D) Again, cell extracts were subjected to immunoblotting 
analysis with antibodies against ERK and phosphorylated ERK (P-ERK). Three independent experiments gave similar results. (E) Comparison of 
the time course of Hes1 oscillation (blue line) and ERK activity oscillation (pink line). to FGF stimulation (Figure 1B,D). The 
periodicity of this oscillation in ERK 
activity was roughly the same as 
that of Hes1 oscillation, with the ERK 
oscillation slightly preceding that of 
Hes1 (Figure 1E). ERK activity did not 
significantly affect the stability of Hes1 
protein (Figure S2). ERK activation is 
therefore required for the FGF-induced 
oscillatory expression of Hes1 and 
oscillations in ERK activity may play a 
role in fine- tuning the Hes1 oscillation.
We then found that ERK activity 
also oscillated in FGF-stimulated NIH 
3T3 cells (Figure 2A,B), with the peak 
activities being significantly dampened 
with time. The oscillatory expression 
of Hes1 was also induced by FGF 
treatment in NIH 3T3 cells (Figure S3). To 
investigate the mechanism underlying 
the oscillation in ERK activity, we then 
measured Ras activity. To our surprise, 
Ras activity (Ras–GTP) also oscillated 
after FGF stimulation (Figure 2A,B): 
in contrast to the oscillation of ERK 
activity, the peak Ras activities were 
not significantly dampened during 
the oscillation progression, whereas 
the trough activities were increased 
(Figure 2A). Ras activity also oscillated 
in FGF-stimulated C3H 10T1/2 cells 
(Figure S1). We confirmed that our assay method specifically recognizes 
Ras–GTP (Figure S4). Ras/ERK 
activities therefore oscillate after FGF 
stimulation and it is possible that these 
oscillations may be more striking when 
assayed at the single-cell level. To 
examine whether FGF receptor activity 
is required for oscillations in Ras/ERK 
activities, we added the specific FGF 
receptor inhibitor SU5402 to cells 
70 min after FGF stimulation and 
observed suppression of later rises in 
Ras and ERK activities (Figure S5). We 
then examined changes in Ras and 
ERK activities in response to EGF. In 
HeLa cells, EGF stimulation induced 
oscillations in Ras activity (Figure S6). 
These data suggest that the sustained 
activation of receptor tyrosine kinase 
is required for oscillations in Ras/ERK 
activities and that a component(s) 
common to both FGF and EGF signaling 
pathways is involved. 
As feedback inhibition should underlie 
oscillatory activation of the signaling 
pathway [4], we directed our attention to 
Sos, the guanine nucleotide exchange 
factor for Ras. ERK-dependent 
phosphorylation of Sos results in its 
dissociation from Grb2 and thus leads to 
Ras inactivation [5–8]. Immunoblotting 
analysis showed that the  mobility-shifted bands of Sos protein, 
which reflect multiple phosphorylation  
of Sos [8], oscillated in response to  
FGF stimulation (Figure 2C). It appeared 
that Sos phosphorylation at 1–10 min 
resulted in Ras inactivation, and Sos 
dephosphorylation at 40–60 min led to 
Ras reactivation (Figure 2C). To examine 
whether ERK activation is sufficient for 
Ras inactivation, we used ∆B-Raf:ER 
cells (NIH 3T3 cells expressing the B-Raf 
kinase domain fused to the estrogen 
receptor ligand- binding domain) [9]. 
Induction of B-Raf activation (at –30 min) 
resulted in sustained ERK activation and 
Sos phosphorylation and led to almost 
complete suppression of FGF-induced 
Ras activation (Figure S7). These 
results suggest that ERK-mediated 
phosphorylation of Sos is a cause of 
Ras inactivation. In fact, when ERK 
activation was suppressed by U0126, 
Sos phosphorylation did not occur and 
Ras activity was sustained at high levels 
(Figure 2C). Moreover, our observation 
that the peak activity of ERK decreased 
with time and the trough activity of 
Ras increased in FGF-stimulated cells 
(Figure 2A,B) is also consistent with the 
above idea. 
To determine whether ERK- mediated 
phosphorylation of Sos is required 
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Figure 2. FGF-induced oscillatory activation of Ras and ERK.
(A) The levels of Ras–GTP, Ras (total), phosphorylated ERK (P-ERK) and ERK (total) were determined in NIH 3T3 cells stimulated with bFGF (25 ng/ml). 
(B) Quantification of the signals of Ras–GTP and P-ERK. (C) ERK-dependent phosphorylation of Sos leads to Ras/ERK inactivation in NIH 3T3 cells. The 
phosphorylation levels of Sos, in addition to Ras-GTP and P-ERK levels, were determined during FGF stimulation in the presence or absence of U0126 
(20 µM). DMSO or U0126 was added 30 min before bFGF stimulation. Essentially the same results were obtained in two independent experiments. The 
upper four rows were from the same series and the bottom row from the other series. (D) Expression of myc–Sos-4A, but not myc–Sos-WT (wild-type), 
abolished FGF-induced Ras activity oscillations. NIH 3T3 cells were cotransfected with FLAG–Ras (250 ng) and myc–Sos-WT or myc–Sos-4A (750 ng). 
Cells were stimulated with bFGF (25 ng/ml) at time 0 and incubated for the indicated times. Three independent experiments gave similar results. for the oscillations in Ras activity, 
we used a Sos mutant, Sos-4A, in 
which the four ERK phosphorylation 
sites are replaced by alanines [8], 
resulting in resistance to ERK- induced 
dissociation of Sos from Grb2 [8]. 
When myc–Sos- WT (wild- type) was 
co-expressed with FLAG–Ras, the Ras 
activity (FLAG–Ras-GTP) oscillated 
after FGF stimulation (Figure 2D). 
In contrast, when myc–Sos-4A was 
co-expressed, the oscillation in Ras 
activity was abolished, and high 
levels of Ras activity were maintained 
(Figure 2D), suggesting that the 
ERK-dependent, negative-feedback 
phosphorylation of Sos is required for 
generating oscillations in Ras/ERK 
activity.
In summary, our results 
demonstrate that growth factor 
stimulation induces oscillations of 
Ras/ERK activities. Although the 
physiological significance is uncertain 
at present, oscillatory Ras/ERK 
activity may act as a novel molecular 
clock.Supplemental data
Supplemental data including experimental 
procedures and supplemental figures are  
available at http://www.current-biology.com/
cgi/content/full/18/8/R332/DC1
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